Market revenue in 2023 | USD 7.6 million |
Market revenue in 2030 | USD 15.3 million |
Growth rate | 10.5% (CAGR from 2023 to 2030) |
Largest segment | Biorepository services |
Fastest growing segment | Biorepository Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biorepository Services, Archiving Solution Services |
Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Biorepository services was the largest segment with a revenue share of 65.79% in 2023. Horizon Databook has segmented the Saudi Arabia clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Availability of low-cost clinical resources, presence of qualified investigators, and ease in patient recruitment are some of the major factors boosting growth of clinical trial biorepository & archiving solutions market in the country.
Advancements in technology, rise in disease prevalence, and quicker regulatory approval as compared to countries such as China, India, and Brazil are some of the factors expected to further fuel growth of clinical trial biorepository & archiving solutions market in the region.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account